Orphan designation: Mibavademab Treatment of Berardinelli-Seip syndrome (congenital generalised lipodystrophy), 21/03/2024 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 23 July 2024 - 13:40

Orphan designation: Mibavademab Treatment of Berardinelli-Seip syndrome (congenital generalised lipodystrophy), 21/03/2024 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-24-2903

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters